iPSC-NPC effects on astrocytes in vitro ICH model

Exploratory Score: 0.900 Price: $0.50 intracerebral hemorrhage in vitro ICH cell culture model with astrocytes Status: proposed

What This Experiment Tests

Exploratory experiment designed to discover new patterns targeting AMPK, mTOR, GFAP, SQSTM1, LC3 in in vitro ICH cell culture model with astrocytes. Primary outcome: astrocyte protection from autophagy

Description

This in vitro experiment investigated the direct effects of iPSC-NPCs on astrocytes using an ICH cell culture model. The study examined how iPSC-NPCs influence astrocyte autophagy and activation through the AMPK/mTOR signaling pathway. Researchers analyzed protein and mRNA expression changes of key autophagy markers including GFAP, AMPK, mTOR, SQSTM1/P62, and LC3 using immunofluorescence techniques. The experiment demonstrated that iPSC-NPCs secrete cytokines that protect astrocytes from autophagy by inhibiting AMPK phosphorylation and promoting mTOR activation. The study also included pharmacological validation using mTOR inhibitors to confirm the pathway involvement.

TARGET GENE
AMPK, mTOR, GFAP, SQSTM1, LC3
MODEL SYSTEM
in vitro ICH cell culture model with astrocytes
ESTIMATED COST
$0
TIMELINE
0 months
PATHWAY
AMPK/mTOR signaling pathway, autophagy regulation
SOURCE
extracted_from_pmid_41921697
PRIMARY OUTCOME
astrocyte protection from autophagy

Scoring Dimensions

Info Gain 0.00 (25%) Feasibility 0.00 (20%) Hyp Coverage 0.00 (20%) Cost Effect. 0.00 (15%) Novelty 0.00 (10%) Ethical Safety 0.00 (10%) 0.900 composite

📖 Wiki Pages

mtor-inhibitor-therapy-parkinsonstherapeuticAMPK Activators for Neurodegenerationtherapeuticampk-activatorstherapeuticSQSTM1/p62 ProteinproteinSQSTM1 Protein (p62/Sequestosome-1)proteinAMPK AlphaproteinMTOR ProteinredirectMTOR ProteinproteinLC3 (Microtubule-Associated Protein 1 Light Chain proteinLC3 ProteinproteinGFAP ProteinproteinAMPK Signaling in NeurodegenerationmechanismAMPK-Mitochondrial Quality Control AxismechanismAMPK Activators for Neurodegeneration — InvestmentinvestmentAMPK Agonist Therapy for Neurodegenerationidea

Protocol

co-culture of iPSC-NPCs with astrocytes, protein and mRNA expression analysis, immunofluorescence, mTOR inhibitor treatment

Expected Outcomes

iPSC-NPCs would protect astrocytes and modulate autophagy pathways

Success Criteria

inhibited AMPK phosphorylation, promoted mTOR activation, reduced autophagy markers

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.